Familial Hypercholesterolemia (FH) and elevated lipoprotein(a) [Lp(a)] are two of the most common genetic lipid disorders: 1 in 311 Canadians have FH and 1 in 5 have high Lp(a). Affected individuals have a higher risk for heart disease and stroke, but both diseases remain underdiagnosed and undertreated. To improve care, increased awareness through education, engagement and dissemination of research findings is vital. The goal of this event is to organize an Educational Patient Engagement Forum focusing on recent developments in the screening, diagnosis and treatment of FH and high Lp(a), and management in specific populations (Indigenous communities and children). The forum will include lectures by those with lived experiences, clinician-scientists, Indigenous researchers, allied health providers, and an interactive session with patients’ testimonials. FH and Lp(a) Canada Registry members will also discuss identification of individuals with inherited lipid disorders, initiatives and resources for patients and health care professionals. The forum will empower patients to become advocates, increase awareness of these diseases, and recognize the importance of screening for early identification, treatment and heart disease reduction.